NCT05745831

Development and Validation of a Therapeutic Decision Aid in Ectopic Pregnancy: GEUDECID Study

Development and Validation of a Therapeutic Decision Aid in Less Active Ectopic Pregnancy

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 109 (actual)
• Sponsor: Institut National de la Santé Et de la Recherche Médicale, France · Other Government
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The aim's study is to validate a therapeutic aid in women with a less active ectopic pregnancy. A prospective recrutement of 100 women will be performed in 16 different hospitals in France. The decision aid will be used and a questionnaire about its usefulness, comprehension and satisfaction will be given to women and doctors.

Detailed description

In less active ectopic pregnancy, two treatments are possible: a medical treatment using methotrexate or a surgical management. A discret choice experiment study was performed to reveal women's preferences between these two options. In conclusion, calculated preferences are 47.5 and 52.5%, revealing a difficult choice for women. This study also lead to identify the main attributes important to make the choice. We were then able to create a therapeutic decision aid to help this shared decision. This aid needs to be validated, following steps for validation. This study is the last step in women in situation of less active ectopic pregnancy.

Conditions

• To Validate a Decision Aid for Ectopic Pregnancy

Interventions

Type	Name	Description
OTHER	Therapeutic decision tool	A therapeutic decision tool will be used and its usefulness, comprehension and satisfaction will be evaluated

Timeline

• Start date: 2023-10-22
• Primary completion: 2024-05-22
• Completion: 2024-05-22
• First posted: 2023-02-27
• Last updated: 2026-01-12

Locations

15 sites across 1 country: France